Figure 6. Impact of 5-aza-2’-deoxycitidine (5-aza) on initiation and completion of perimenopause.
A) Survival curve analysis indicated a non-significant acceleration to initiation of perimenopause in 5-aza-treated animals. B) 5-aza significantly accelerated progression through the perimenopausal transition to menopausal acyclicity (Mantel-Cox p= 0.0043 ; Gehan-Brewslow-Wilcoxon p= 0.006).